Lars König is a Director of In Situ Therapy at BioNTech SE and a Group Leader at Ludwig-Maximilians-Universität München. They have a rich academic background with a Bachelor of Science and a Master of Science from Ruprecht-Karls-Universität Heidelberg, followed by a PhD in Molecular & Cellular Immunology from Georg-August-Universität Göttingen. Lars has held various significant positions, including Associate Director of In Situ Therapy at BioNTech SE and has focused their research on innate immunity in the context of immunotherapy. Currently engaged in habilitation at Ludwig-Maximilians-Universität München, Lars continues to advance the field of immunology through their work.
This person is not in the org chart
This person is not in any teams
This person is not in any offices